Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuregulin-1 | 4 | 2023 | 142 | 1.020 |
Why?
|
| Sarcoma, Clear Cell | 1 | 2022 | 76 | 0.830 |
Why?
|
| Receptor, erbB-3 | 3 | 2023 | 142 | 0.830 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 6 | 2023 | 5223 | 0.700 |
Why?
|
| Lung Neoplasms | 8 | 2023 | 13104 | 0.650 |
Why?
|
| Gene Fusion | 1 | 2021 | 371 | 0.620 |
Why?
|
| MAP Kinase Signaling System | 1 | 2022 | 1525 | 0.500 |
Why?
|
| Proteomics | 3 | 2023 | 3638 | 0.420 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2022 | 1363 | 0.420 |
Why?
|
| Desmoplastic Small Round Cell Tumor | 2 | 2022 | 26 | 0.400 |
Why?
|
| Protein Kinase Inhibitors | 5 | 2023 | 5534 | 0.380 |
Why?
|
| Sarcoma | 1 | 2022 | 1897 | 0.370 |
Why?
|
| Gene Expression | 1 | 2021 | 7798 | 0.310 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2022 | 1581 | 0.270 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8432 | 0.270 |
Why?
|
| Melanoma | 1 | 2022 | 5511 | 0.240 |
Why?
|
| S100 Proteins | 1 | 2022 | 259 | 0.210 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2023 | 4554 | 0.200 |
Why?
|
| MyoD Protein | 1 | 2022 | 151 | 0.200 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2021 | 72 | 0.190 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 16690 | 0.180 |
Why?
|
| Receptor, trkA | 1 | 2020 | 164 | 0.180 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2020 | 216 | 0.170 |
Why?
|
| Indazoles | 1 | 2020 | 290 | 0.170 |
Why?
|
| Rhabdomyosarcoma | 1 | 2022 | 382 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2021 | 3554 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 475 | 0.160 |
Why?
|
| Pathology, Molecular | 1 | 2021 | 326 | 0.150 |
Why?
|
| Receptor, erbB-2 | 3 | 2023 | 2417 | 0.150 |
Why?
|
| Telomerase | 1 | 2021 | 730 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2022 | 988 | 0.140 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2023 | 808 | 0.130 |
Why?
|
| Neoplasms | 2 | 2021 | 21696 | 0.130 |
Why?
|
| Benzamides | 1 | 2020 | 1379 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2022 | 2455 | 0.130 |
Why?
|
| Language | 1 | 2024 | 1471 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 1660 | 0.120 |
Why?
|
| Mutation | 6 | 2023 | 29786 | 0.120 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2022 | 11366 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2021 | 2110 | 0.100 |
Why?
|
| Receptor, trkC | 2 | 2020 | 68 | 0.100 |
Why?
|
| WT1 Proteins | 2 | 2022 | 178 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 2249 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2022 | 5172 | 0.090 |
Why?
|
| Medical Oncology | 1 | 2021 | 2267 | 0.080 |
Why?
|
| Humans | 17 | 2024 | 744366 | 0.080 |
Why?
|
| Protein Binding | 1 | 2021 | 9384 | 0.080 |
Why?
|
| Oncogenes | 2 | 2022 | 1265 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2023 | 6364 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 5263 | 0.060 |
Why?
|
| Mice | 5 | 2022 | 81201 | 0.060 |
Why?
|
| Prognosis | 1 | 2023 | 29060 | 0.060 |
Why?
|
| Solvents | 1 | 2023 | 302 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2023 | 23404 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 8861 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 1 | 2021 | 199 | 0.050 |
Why?
|
| Chromogranins | 1 | 2022 | 160 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2023 | 381 | 0.050 |
Why?
|
| Female | 4 | 2023 | 380193 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 647 | 0.050 |
Why?
|
| Antibodies, Bispecific | 1 | 2022 | 164 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2022 | 199 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 644 | 0.040 |
Why?
|
| Molecular Conformation | 1 | 2020 | 562 | 0.040 |
Why?
|
| Workflow | 1 | 2024 | 847 | 0.040 |
Why?
|
| Young Adult | 2 | 2022 | 56429 | 0.040 |
Why?
|
| Animals | 5 | 2022 | 168768 | 0.040 |
Why?
|
| Male | 3 | 2023 | 350115 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2022 | 1179 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 1085 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2022 | 1142 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 1692 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 3130 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2022 | 2504 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2023 | 12207 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 5451 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2021 | 3024 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 3595 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 4561 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3464 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 13035 | 0.020 |
Why?
|
| Disease Progression | 1 | 2023 | 13286 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9240 | 0.010 |
Why?
|
| Child | 2 | 2022 | 77709 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 18034 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 214052 | 0.010 |
Why?
|
| Brain | 1 | 2023 | 26388 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77460 | 0.010 |
Why?
|
| Adolescent | 1 | 2020 | 85779 | 0.010 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_